Billion 4G/LTE Outdoor VPN Routers are the New Backhauls of LoRa Meters for Remote Reading and Billing
Billion Electric, the leading global telecommunication technology and IoT solutions provider, introduces an outstanding integration between LoRa smart meters and its high-performance 4G/LTE Outdoor SIM Embedded VPN Router – BiPAC 4700ZU. Incorporated with the latest 4G/LTE technology, dual-polarized MIMO antenna, VPN, and IP67 enclosure, BiPAC 4700ZU enables automatic electricity meter reading and billing solution in rural mountains by connecting the LoRa-based smart meters to the utility company for automatic control.
To control the electricity that is supplied to the households in rural mountain areas, the utility company installed Billion 4700ZU Outdoor 4G/LTE Routers, serving as the backhaul to transmit data collected from each LoRa meters in households to the utility company’s Central Metering Control System. Based on the data, the system could automatically read, activate and deactivate the identified smart meters. By connecting the meter reading, controlling, and billing process to the Internet, the utility company was able to reduce the financial expense on hiring labors to record the reading manually.
Featuring IP67 rugged enclosure and a broad range of operating temperature from -40°C-60°C/-40°F-140°F, BiPAC 4700ZU can endure the most challenging weathers and environments. Integrating with the 4G/LTE and optimal MIMO antenna, BiPAC 4700ZU can maximize LTE service coverage with data rate up to 100Mbps downlink and 50Mbps uplink. BiPAC 4700ZU can be flexibly positioned on any exterior wall, chimneys, or poles with the mounting kit.
BiPAC 4700ZU also supports robust VPN including IPSec/PPTP/L2TP/GRE, allowing users to establish private encryption tunnels over the public Internet to secure billing data transmission. “Through the implementation of BiPAC 4700ZU and the LoRa metering system, the grid company could access to the prepaid billing data and activate the household electricity supply in real time. BiPAC 4700ZU not only enhanced the traditional metering and billing system, but also helped the grid company to improve the efficiency of their service distribution process and corporate competitiveness”, said William Lee, the Sensor Product Manager of Billion Electric Co., Ltd.
BiPAC 4700ZU - 4G LTE SIM embedded Outdoor VPN Router http://www.billion.com.tw/Communication/4G%7CLTE%20Series/BiPAC%204700ZU
Billion Electric (TAIEX：3027, www.billion.com ) is committed to acting as responsible corporate citizens, innovative enablers for the information society, and collaborative contributors to the industry through creating maximum value for global telecom operators.
Billion Electric Co. Ltd.
Jesse Chen, Marketing Strategist
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
ASTRAZENECA10.12.2017 23:47 | pressemeddelelse
AstraZeneca’s Calquence (acalabrutinib) Shows Potential in Chronic Lymphocytic Leukaemia Trials
NJ-CELGENE/BLUEBIRD-BIO10.12.2017 16:32 | pressemeddelelse
Celgene Corporation and bluebird bio Announce Updated Results from Ongoing Multicenter Phase 1 Study of bb2121 Anti-BCMA CAR T Cell Therapy in Patients with Late Stage Relapsed/Refractory Multiple Myeloma at ASH Annual Meeting
GA-GILEAD-SCIENCES/KITE10.12.2017 16:32 | pressemeddelelse
Kite Announces Long-Term Data From Pivotal ZUMA-1 Study of Yescarta™ (Axicabtagene Ciloleucel) in Patients With Refractory Large B-cell Lymphoma
MA-TAKEDA/SEATTLE10.12.2017 14:02 | pressemeddelelse
Takeda and Seattle Genetics to Present Positive Data from Phase 3 ECHELON-1 Clinical Trial Evaluating ADCETRIS® (brentuximab vedotin) in Frontline Advanced Hodgkin Lymphoma
ASTRAZENECA9.12.2017 19:02 | pressemeddelelse
AstraZeneca’s Calquence (acalabrutinib) Demonstrates Activity in Relapsed or Refractory Mantle Cell Lymphoma Trial
JANSSEN9.12.2017 18:21 | pressemeddelelse
Sustained Benefit in Patients with Relapsed/Refractory Mantle Cell Lymphoma Demonstrated by 3.5 Year Follow-up Data of Imbruvica®▼(ibrutinib)
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum